sodium oxybate
Drug ingredientThis chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.
Where It Comes From
15 FDA-registered drug labelers
Amneal Pharmaceuticals LLC
Avadel CNS Pharmaceuticals, LLC
Camber Pharmaceuticals, Inc.
Cambrex Charles City, Inc
Catalent Pharma Solutions, LLC
Chattem Chemicals, Inc.
Curia Missouri, Inc.
Curia New York, Inc.
Granules India Limited
Hikma Pharmaceuticals USA Inc.
Jazz Pharmaceuticals, Inc.
MERIBEL PHARMA PESSAC
Siegfried USA, LLC
Veranova, L.P.
XLCare Pharmaceuticals, Inc.
Why It Matters
Sectors
Health
Downstream Uses
Appears in 4 drug and cosmetic product listings (FDA).
- •sodium oxybate
- •Lumryz
- •Xyrem
- •Xywav
FDA Shortage Status
Whether any manufacturer currently reports this drug as in shortage on the FDA Drug Shortages database. "Active Shortage" means at least one presentation has status "current."
No Shortage
Shortage History
Each row is a separate manufacturer's FDA shortage filing — not a timeline for the drug as a whole. Multiple "current" entries are normal: each manufacturer/NDC files independently. Status reflects the manufacturer's report; reason describes their supply situation (Available, Unavailable, or to be discontinued).
to be discontinued
Sodium Oxybate Solution
12/29/2025Chemical Identity
CAS502-85-2
PubChem CID23663870
DTXSIDDTXSID3048940
FormulaC4H7NaO3
Mol. Weight126.09 g/mol
SMILESC(CC(=O)[O-])CO.[Na+]
Data Sources
236638702026-04-07
https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/name/sodium oxybate/cids/JSON
Archive: data/sources/pubchem_name/sodium oxybate.json
CAS 502-85-22026-04-24
https://www.epa.gov/tsca-inventory
Archive: data/sources/tsca/tsca_inventory.csv
CAS 502-85-22026-06-13
https://api.fda.gov/drug/shortages.json
Archive: data/sources/fda/shortages/shortages.json